We are live on ! Find out more
PALI icon

Palisade Bio
PALI

15 hedge funds and large institutions have $385K invested in Palisade Bio in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more capital invested

Capital invested by funds: $242K → $385K (+$143K)

0.47% more ownership

Funds ownership: 0.22% → 0.69% (+0.47%)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$335K
2
HF
HRT Financial
New York
+$15K
3
Millennium Management
Millennium Management
New York
+$8.46K
4
TSS
Two Sigma Securities
New York
+$3.98K
5
BL
BFSG LLC
California
+$21

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$32K
2
VF
Virtu Financial
New York
-$31K
3
WAM
Warberg Asset Management
Illinois
-$5.9K
4
Morgan Stanley
Morgan Stanley
New York
-$977
5
UBS Group
UBS Group
Switzerland
-$140
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$287K +$335K +48,000 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$27.2K – – –
MG
3
Marex Group
$14.3K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$13.7K – – –
HF
5
HRT Financial
New York
$12K +$15K +2,155 New
TSS
6
Two Sigma Securities
New York
$11.3K +$3.98K +571 +44%
State Street
7
State Street
Massachusetts
$8.96K – – –
Millennium Management
8
Millennium Management
New York
$7.26K +$8.46K +1,213 New
UBS Group
9
UBS Group
Switzerland
$887 -$140 -20 -12%
Morgan Stanley
10
Morgan Stanley
New York
$841 -$977 -140 -50%
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$599 – – –
Wells Fargo
12
Wells Fargo
California
$164 +$7 +1 +4%
OCM
13
Orion Capital Management
California
$119 – – –
BL
14
BFSG LLC
California
$16 +$21 +3 New
BlackRock
15
BlackRock
New York
$4 – – –
Fidelity Investments
16
Fidelity Investments
Massachusetts
$1 -$21 -3 Closed
Renaissance Technologies
17
Renaissance Technologies
New York
– -$32K -3,653 Closed
VF
18
Virtu Financial
New York
– -$31K -3,462 Closed
WAM
19
Warberg Asset Management
Illinois
– -$5.9K -667 Closed
Northwestern Mutual Wealth Management
20
Northwestern Mutual Wealth Management
Wisconsin
– -$1 – –

PALI Hedge Fund Activity: Q1 2024 in Review

15 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2024, worth a combined $385K — up 59% from $242K a quarter earlier.

Fund positioning in PALI was balanced in Q1 2024: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $335K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $32K sold.

  • 15 institutional investors held Palisade Bio (PALI) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $385K of Palisade Bio stock for Q1 2024, up 59% quarter-over-quarter.
  • 4 funds opened new Palisade Bio positions in Q1 2024 and 4 closed out, a net change of 0 holders.
  • The largest Palisade Bio buyer in Q1 2024 was Armistice Capital, an estimated $335K added.
  • The largest Palisade Bio seller in Q1 2024 was Renaissance Technologies, an estimated $32K sold.

Based on aggregated 13F filings for Q1 2024.